- Home
- AKRO vs EFSC Comparison
AKRO vs EFSC Comparison
Compare AKRO & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- EFSC
- Stock Information
- Founded
- AKRO 2017
- EFSC 1988
- Country
- AKRO United States
- EFSC United States
- Employees
- AKRO N/A
- EFSC N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- EFSC Major Banks
- Sector
- AKRO Health Care
- EFSC Finance
- Exchange
- AKRO Nasdaq
- EFSC Nasdaq
- Market Cap
- AKRO 3.9B
- EFSC 2.0B
- IPO Year
- AKRO 2019
- EFSC 1999
- Fundamental
- Price
- AKRO $51.69
- EFSC $57.36
- Analyst Decision
- AKRO Strong Buy
- EFSC Strong Buy
- Analyst Count
- AKRO 6
- EFSC 3
- Target Price
- AKRO $82.50
- EFSC $64.33
- AVG Volume (30 Days)
- AKRO 1.6M
- EFSC 207.4K
- Earning Date
- AKRO 08-08-2025
- EFSC 07-28-2025
- Dividend Yield
- AKRO N/A
- EFSC 2.10%
- EPS Growth
- AKRO N/A
- EFSC 9.23
- EPS
- AKRO N/A
- EFSC 5.09
- Revenue
- AKRO N/A
- EFSC $619,222,000.00
- Revenue This Year
- AKRO N/A
- EFSC $14.06
- Revenue Next Year
- AKRO N/A
- EFSC $4.85
- P/E Ratio
- AKRO N/A
- EFSC $11.25
- Revenue Growth
- AKRO N/A
- EFSC 6.50
- 52 Week Low
- AKRO $21.34
- EFSC $39.47
- 52 Week High
- AKRO $58.40
- EFSC $63.13
- Technical
- Relative Strength Index (RSI)
- AKRO 45.35
- EFSC 65.09
- Support Level
- AKRO $50.13
- EFSC $56.49
- Resistance Level
- AKRO $53.60
- EFSC $58.17
- Average True Range (ATR)
- AKRO 2.03
- EFSC 1.14
- MACD
- AKRO -0.83
- EFSC 0.23
- Stochastic Oscillator
- AKRO 6.37
- EFSC 85.38
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.